3ShimuraM,YasudaK,ShionoT.Posterorsub-Tenon ' scapsuleinjection of triamcinolone acetonide prevents panretinal photocoagulation- induced visual dysfunction in patient with severe diabetic retinopathy and good vision.Ophthalmology,2006, 113(3): 381-387.
4Shimura M,Yasuda K,Nakazawa T,et al Quantifying alterations of macular thickness before and after panretinal photocoagulation in patients with severe diabetic retinopathy and good vision.Ophthalm ology,2003,110(12) :2386-2394.
3Prokofyeva E, Zrenner E. Epidemiology of major eye diseases leading to blindness in Europe: a literature review [ J ]. Ophthalmic Res, 2012, 47 (4): 171-188. DOI: 10. 1159/ 000329603.
4Ceriello A, Esposito K, Piconi L, et al. Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients [ J ]. Diabetes, 2008, 57 (5) : 1349-1354. DOI: 10. 2337/db08- 0063.
5Shimura M, Yasuda K, Shiono T. Posterorsub-Tenon's capsule injection of triamcinolone acetonide prevents panretinal photoeoagulation-induced visual dysfunction in patient with severe diabetic retinopathy and good vision[ J]. Ophthalmology, 2006, 113(3) : 381-387.
6Merante D, Menchini F, Truitt KE, et al. Diabetic macular edema: correlations with available diabetes therapies-evidence across a qualitative review of published literature from MEDLINE and EMBASE[J]. Drug Saf, 2010, 33(8) : 643-652. DOI 10. 2165/11538340-000000000-00000.
7Shimura M, Yasuda K, Nakazawa T, et al. Quantifying alterations of maeular thickness before and after panretinalphotocoagulation in patients with severe diabeti cretinopathy and good vision [ J ]. Ophthalmology, 2003, 110 (12) : 2386-2394.
